BDBM632954 US12172993, Compound C2::US20230348453, Compound C2

SMILES Cc1cccnc1NC(=O)c1cnc(Nc2cc(nc(C)n2)N2CCN(CCO)CC2)s1

InChI Key InChIKey=HYMHVNNHIASECU-UHFFFAOYSA-N

Data  10 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 632954   

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632954(US20230348453, Compound C2 | US12172993, Compound ...)
Affinity DataIC50: 1.5nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632954(US20230348453, Compound C2 | US12172993, Compound ...)
Affinity DataIC50: 1.5nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632954(US20230348453, Compound C2 | US12172993, Compound ...)
Affinity DataIC50: 14.4nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632954(US20230348453, Compound C2 | US12172993, Compound ...)
Affinity DataIC50: 14.4nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase SIK1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632954(US20230348453, Compound C2 | US12172993, Compound ...)
Affinity DataIC50: 177nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase SIK1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632954(US20230348453, Compound C2 | US12172993, Compound ...)
Affinity DataIC50: 177nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632954(US20230348453, Compound C2 | US12172993, Compound ...)
Affinity DataIC50: 427nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632954(US20230348453, Compound C2 | US12172993, Compound ...)
Affinity DataIC50: 427nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632954(US20230348453, Compound C2 | US12172993, Compound ...)
Affinity DataIC50: 1.10E+3nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632954(US20230348453, Compound C2 | US12172993, Compound ...)
Affinity DataIC50: 1.10E+3nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent